ClinicalTrials.gg
Drug

Candesartan cilexetil clinical trials

Also written Atacand and Atacand 16mg.

A product of Candesartan; its studies count on that page too.

studies test it
39
open now
2
in phase 3
14
first study started
1998

How each study uses candesartan cilexetil is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the candesartan cilexetil studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
4 Jun 1998 · ATACAND · NDA 020838 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Candesartan cilexetil
20
Candesartan cilexetil 16mg
3
Candesartan
2
Candesartan Cilexetil 32mg
2
Candesartan cilexetil (GW615775, Test formulation)
2

Brand

Atacand
16
Atacand 16mg
3
Atacand 8mg
3

Studies by the year they started

38 studies that test it; most in 2013 (5)

Studies that test candesartan cilexetil, by start year
YearStudies
19982
20012
20031
20041
20054
20062
20073
20081
20093
20101
20111
20135
20144
20152
20171
20191
20221
20231
20241
20261

By phase

A phase 1/2 study counts in both.

Phase 1
10
Phase 2
8
Phase 3
14
Phase 4
8

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 25 · Other 14

AstraZeneca (10) · HK inno.N Corporation (3) · GlaxoSmithKline (3) · Shin Poong Pharmaceutical Co. Ltd. (2) · Takeda (2) · Hospital Israelita Albert Einstein (1) · Uppsala University (1) · Pharmtechnology LLC (1)

Often tested with

Tested in the same studies.

Amlodipine (5) · Hydrochlorothiazide (3) · Lisinopril (2) · Ramipril (2) · Chlorthalidone (1) · Rosuvastatin (1) · Allopurinol (1) · Fimasartan (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses candesartan cilexetil is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 39

See all 39 studies that test candesartan cilexetil →

Given beside what is tested · 6 — candesartan cilexetil is usual care or a partner of the new treatment
As the comparator · 8 — what is tested is compared with candesartan cilexetil

Codes

What other systems call candesartan cilexetil · ClinicalTrials.gg INT003675

  • MeSH (NLM) C077793candesartan cilexetilConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) R85M2X0D68CANDESARTAN CILEXETILConfirmed FDA, NLM, Wikidata
  • RxNorm 135481Confirmed FDA, Wikidata
  • Wikidata Q27075664candesartan cilexetilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C28903Candesartan CilexetilOne source FDA
  • DrugBank DB00796One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.